NGT BioPharma Consultants provide Late Discovery services focused on clinical candidate selection and the development of suitable data packages supporting candidate advancement into preclinical development for both traditional small molecule pharmaceuticals as well as biologics (Mabs, duobodies, proteins, cell therapy, gene therapy, and new modalities).


Our diverse team of experienced consultants provides a broad range of expertise in translational pharmacology, preclinical toxicology, PK/PD relationships, physicochemical properties, synthesis development, CRO engagement, intellectual property, due diligence, and backup candidate strategy/development.  

Screen Shot 2022-06-20 at 7.14.10 PM

For more information
please contact:

Michael Neeb

860.333.9023 ext. 405

OR Contact:

Rachel Franckowiak

Senior Director, Administration